Additional studies have also shown that patients taking GLP-1 receptor agonists also have significantly lower rates of kidney outcomes such as macroalbuminuria or progression to end-stage kidney disease
In a randomized placebo-controlled trial on 20 obese, glucose-tolerant patients with plaque PsO no significant change in PASI, DLQI and high sensitive CRP were observed after 8 weeks treatment with liraglutide compared to placebo group [155]
Weight may increase slightly, partly from water retention as GLP-1 mediated effects on fluid balance normalize
While regulatory standards ensure safety and functionality, addressing the unique needs of GLP-1 users for weight loss offers an opportunity to go beyond compliance, creating solutions that are not only practical but also deeply engaging
Each bottle provides 140 calories, 20 grams of protein, and 4 grams of fiber, making it a protein-forward option that can still fit into a lower-calorie day